Mulberry Pollen Allergy: A Significant Spring Aeroallergen in the Eastern US

Mulberry pollen allergy is an IgE-mediated spring pollinosis triggered by the wind-borne pollen of Morus trees — primarily white mulberry (Morus alba) and red mulberry (Morus rubra) — which are widespread across the eastern and central United States. While precise prevalence data for mulberry-specific sensitization are limited because mulberry is not always included in standard allergy test panels, it is a clinically significant contributor to spring allergic rhinitis in regions where Morus species are abundant. Among the estimated 50 million Americans with allergic rhinitis, a substantial subset in mulberry-dense areas are sensitized to mulberry pollen. The allergy is most common in the Midwest, Southeast, and Mid-Atlantic states where white mulberry has naturalized extensively as an invasive species and male cultivars are widely planted as urban shade trees.

Mulberry pollen allergy produces the classic spring hay fever symptom complex: paroxysmal sneezing, nasal congestion, clear watery rhinorrhea, and intense itching of the nose, palate, and eyes. Allergic conjunctivitis — bilateral itchy, watery, red eyes — is prominent during peak pollen days. These symptoms are driven by histamine release from mast cells when mulberry pollen contacts the nasal and conjunctival mucosa of sensitized individuals. Some patients also experience postnasal drip, throat clearing, fatigue from poor sleep quality due to nighttime congestion, and oral allergy syndrome (mouth and throat itching) when eating raw fig or jackfruit — Moraceae family foods that share cross-reactive proteins with mulberry pollen. Symptoms are seasonal, peaking in April and May, and resolve when the mulberry bloom ends.

Mulberry pollen season runs primarily from April through May across most of the eastern and central United States. In the Deep South and Gulf Coast states, mulberry bloom may begin as early as late March, while in the Upper Midwest and northern New England, the season can extend into early June. The peak pollen release window is approximately 3–4 weeks, during which male mulberry trees can release millions of pollen grains per day. Warm, dry, breezy days produce the highest airborne pollen concentrations. Mulberry pollen season overlaps significantly with other major spring tree pollens — oak, birch, maple, elm, and hickory — creating a combined high-intensity aeroallergen environment that drives peak spring allergy symptoms for tens of millions of Americans.

Mulberry pollen allergy is diagnosed through a combination of clinical history and objective allergy testing. The key historical feature is predictable rhinoconjunctivitis every April and May, particularly in regions where mulberry trees are abundant. Skin prick testing (SPT) is the first-line diagnostic modality — a spring tree pollen panel that includes mulberry extract (where available) can confirm sensitization within 15–20 minutes. Where mulberry-specific extract is not available, testing for the broader spring tree panel (oak, birch, maple, elm) identifies the pattern of tree pollen sensitization that strongly suggests mulberry co-sensitization in the appropriate geographic context. Specific IgE blood testing (ImmunoCAP) is an alternative for patients who cannot discontinue antihistamines. A board-certified allergist interprets test results alongside the patient's symptom diary and local pollen calendar to establish the diagnosis.

Yes, mulberry pollen allergy can cause oral allergy syndrome (OAS) due to cross-reactive proteins shared within the Moraceae plant family. The most commonly implicated foods are raw fig (Ficus carica) and raw jackfruit (Artocarpus heterophyllus), both of which belong to the Moraceae family alongside mulberry. When a mulberry-sensitized patient eats these raw foods, cross-reactive pollen-food proteins contact the oral mucosa and trigger localized IgE-mediated mast cell degranulation, causing itching, tingling, or mild swelling of the lips, mouth, and throat. These symptoms are typically mild, develop within minutes of eating, and resolve spontaneously within 30 minutes. The cross-reactive proteins are heat-labile, so cooked or processed fig and jackfruit products are usually well-tolerated. Systemic reactions are uncommon with pollen-food OAS.

The best treatment for mulberry pollen allergy depends on symptom severity and patient preference. For mild intermittent symptoms, second-generation oral antihistamines (cetirizine, loratadine, fexofenadine) taken daily during the April–May pollen season provide effective relief. For moderate-to-severe or persistent symptoms, intranasal corticosteroids (fluticasone, mometasone, triamcinolone) are the most effective single-agent therapy — meta-analyses show they outperform antihistamines alone for total symptom control. Antihistamine eye drops address ocular symptoms specifically. For patients who do not achieve adequate control with pharmacotherapy or who wish to reduce long-term medication dependence, allergen immunotherapy — either subcutaneous (allergy shots) or sublingual (allergy drops) — is the only disease-modifying treatment that retrains the immune system to tolerate mulberry pollen, with 60–80% long-term symptom reduction demonstrated in clinical trials.

Mulberry trees are primarily wind-pollinated, which is why they are significant aeroallergens. Unlike many flowering fruit trees that rely on bees and other insects for pollination, mulberries produce lightweight, abundant pollen designed for wind dispersal. Male mulberry trees (the pollen-producing sex, since mulberries are dioecious with separate male and female trees) release millions of pollen grains that can travel considerable distances on spring breezes. This wind-pollination strategy is the key reason mulberry pollen becomes airborne in clinically significant concentrations. The fruitless male cultivars commonly planted as urban shade trees are particularly problematic because they produce pollen without the 'messy' fruit that might discourage planting — meaning they are widely distributed in residential areas where they concentrate allergenic pollen near homes, schools, and parks.

Allergen immunotherapy — both subcutaneous (allergy shots) and sublingual (allergy drops) — is the closest available approach to a long-term solution for mulberry pollen allergy, though it is more accurately described as inducing sustained tolerance rather than a cure. Immunotherapy works by administering gradually increasing doses of mulberry pollen extract over 3–5 years, retraining the immune system to recognize mulberry pollen as harmless rather than triggering an allergic response. Clinical trials demonstrate that 60–80% of patients experience clinically meaningful and sustained symptom reduction that persists for years after treatment completion. Without immunotherapy, spontaneous resolution of established seasonal allergic rhinitis in adults is uncommon — most patients continue to experience symptoms each spring. Pharmacotherapy (antihistamines, nasal steroids) controls symptoms effectively but does not modify the underlying allergic disease.

Yes, mulberry pollen allergy is related to fig and jackfruit allergy through the Moraceae plant family connection. Mulberry (Morus), fig (Ficus), and jackfruit (Artocarpus) all belong to the Moraceae family and share structurally similar allergenic proteins. A patient sensitized to mulberry pollen may have IgE antibodies that cross-recognize homologous proteins in raw fig or jackfruit, triggering oral allergy syndrome upon consumption. This is a cross-reactivity phenomenon — the primary sensitization is to the pollen, and the food reaction is secondary. The cross-reactive proteins are typically heat-labile, meaning cooking denatures them and cooked fig or jackfruit is usually tolerated. Not all mulberry-sensitized patients will react to these foods; the cross-reactivity is clinically significant in a subset of patients and should be evaluated individually by an allergist.

Removing a male mulberry tree from your property can reduce your closest and most concentrated pollen exposure, but it will not eliminate mulberry pollen allergy entirely because wind-dispersed pollen travels miles from neighboring trees. If you have a fruitless male mulberry cultivar on your property — identifiable by the absence of fruit and the presence of catkin-like pollen structures in spring — removing it eliminates the pollen source directly outside your window. However, regional mulberry pollen from trees in your neighborhood and beyond will still be present in the air during April and May. Tree removal is one component of a comprehensive management strategy that should also include pharmacotherapy, indoor environmental controls, and consideration of immunotherapy for long-term desensitization. Before removing a tree, confirm with a local arborist or extension service that it is indeed a male mulberry, as female trees produce no pollen.